Trial Condition(s):
Preferences & Treatment Satisfaction Drivers in Rosacea Patients
To survey patients with rosacea about their rosacea treatment preferences as well as to assess potential drivers of rosacea treatment satisfaction.
- Male or female patients of at least 18 years of age at index date - At least one prescription for a topical rosacea treatments: Azelaic Acid Gel, Azelaic Acid Cream, Metronidazole Gel, Metronidazole Cream, Metronidazole Emulsion, Metronidazole Lotion, Brimonidine Tartrate Gel - At least one medical record with a diagnosis code for rosacea (ICD-9: 695.3) - At least 6 months of data history prior to the index date - Had at least one encounter at the Reliant Medical Group within 3 months prior to 01 January 2015
- None
Locations | Status | ||
---|---|---|---|
Locations Investigative Site Boston, United States | Status Completed | Contact Us: E-mail: [email protected] Phone: +49 30 300139003 |
A Study of Patient Preferences and Drivers of Treatment Satisfaction in Patients with Rosacea
Trial Type:
Observational
Intervention Type:
Drug
Trial Purpose:
N/A
Allocation:
N/A
Blinding:
N/A
Assignment:
N/A
Trial Arms:
1